Medical Design and Outsourcing Archives - Page 17 of 154

ResMed executive pay increases; CEO’s total comp jumped 19%

Resmed logo

ResMed recently disclosed pay packages for its top executives, reporting boosts in total compensation for its CEO and his leadership team.

The respiratory device manufacturer has had the market mostly to itself ever since 2021, when competitor Philips started recalling millions of Respironics continuous positive airway pressure (CPAP) machines. Despite that advantage, ResMed has struggled to ramp up manufacturing volume, sales and profitability due to supply chain challenges, including shortages of semiconductors and other electronic components as well as higher costs for components, manufacturing and warehousing.

ResMed closed fiscal 2023 (ended June 30, 2023) with year-over-year revenue growth of 23% and net income growth of 15%. But the company’s fourth-quarter results disappointed analysts, and its stock has been sliding ever since.

ResMed’s top-paid executives

Intricon names medical device veteran as CFO

NEWS RELEASE: Intricon names medical device veteran as CFO

Intricon CFO Shaun Blakeman [Photo courtesy of Intricon]

ST. PAUL, Minn. (Oct. 11, 2023) — Intricon, developer and manufacturer of medical devices powered by smart miniaturized electronics, today announced that it has named Shaun Blakeman as its chief financial officer (CFO) and newest member of its executive team.

“Shaun is a seasoned global financial executive with 25+ years of operational and broad business experience as well as a proven record of results-driven impact,” said Scott Longval, Intricon chief executive officer. “I am confident we will benefit from Shaun’s leadership as we continue to transform the organization to drive enhanced growth, innovation, and value for our customers.”

Scott added that Shaun was selected given his deep understanding of the medical device industry and his expertise in finance for global businesses. He…

Connectivity is critical as the need grows for patient monitoring

Patient monitoring device connectors will need to be more compact, more durable, and handle higher data rates.

By Rick Lopez, Paul Pulkowski and Jana Wagner, binder

By 2050, the number of people who will be age 60 or older is expected to double to 2 billion worldwide. During the same period, the number of persons aged 80 and older is predicted to triple to about 430 million.

This demographic shift is already creating higher demand for a wide range of medical equipment and services. The growing number of chronically ill patients in Western society will further increase the need for medical technology in the coming decades. An alarming 70% of deaths worldwide are caused by noncommunicable diseases such as heart failure, diabetes, and cancer. Because these are chronic conditions, patients and healthcare providers regularly monitor changes in indicators such as glucose levels and blood pressure.

Patient monitoring refers to observing, tracking, and analyzin…

Patient-centered VR design fuels Penumbra’s Immersive Healthcare future

Penumbra President of Immersive Healthcare Gita Barry [Image courtesy of Penumbra]

Penumbra is leveraging virtual reality to transform how patients interact with their care, offering therapeutic devices that give clinicians the tools to monitor and enhance therapy outcomes.

The company’s immersive healthcare division is developing virtual reality (VR) technology to enhance patient care. The REAL system gives clinicians tools to monitor patient progress, improve engagement and enhance satisfaction during rehabilitation, as well as address cognition and mental wellbeing. By integrating VR technology with patient-centric design principles, Penumbra aims to transform the therapy experience.

“It’s a really different point of view. It’s leveraging the perspective of Penumbra versus a lot of the other companies that are in the space,” Penumbra Immersive Healthcare President Gita Ba…

Intuitive’s Kathryn Rieger on human factors design in surgical robotics

Kathryn Rieger, head of human factors and user research at Intuitive Surgical, explains how the surgical robotics developer approaches product design.

Intuitive Surgical Senior Director for Human Factors and User Research Kathryn Rieger [Photo courtesy of Intuitive]

Intuitive Surgical Senior Director for Human Factors and User Research Kathryn Rieger credits the Presto Hot Dogger for her career in medtech.

“If you Google it, you will see it is not a very well-designed product,” she recalls. “It was designed to cook six hotdogs in 60 seconds. Essentially, it had these big spikes that you impale the hotdogs onto [and it] was a circuit that you completed like a good old-fashioned science project to cook the hotdogs.”

So what’s the connection between meat-tech and medtech? Rieger found herself facing the frankfurter-frying contraption in her first day of “Bad Product Desig…

Stryker CEO Kevin Lobo offers supply chain update after ‘wild year’

Kevin Lobo is CEO and chair of Stryker. [Photo courtesy of Stryker]

The medtech industry as a whole suffered over the past year or so as supply chain issues — namely semiconductors — came to a head.

Midway through last year, Medtronic CEO Geoff Martha labeled it as a problem for everyone as medtech’s biggest names navigated serious shortages of chips and other key supplies.

An industry survey from Deloitte showed that some medtech manufacturers slowed down or halted manufacturing operations after depleting their semiconductor inventories. Nearly 80% of survey respondents reported extended lead times, with some stretching more than a year.

At AdvaMed’s The MedTech Conference on Monday in Anaheim, Stryker Chair and CEO Kevin Lobo explained the low point that his company and the industry hit last year.

“In this industry, we never had to worry about [chip supply] before,” Lobo…

Integer exhibits at 2023 MD&M Minneapolis Expo

NEWS RELEASE: Integer to Exhibit at 2023 MD&M Minneapolis Expo, Oct. 10 – 11

PLANO, Texas, Oct. 06, 2023 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M Minneapolis Exposition from Oct. 10 – 11, 2023, at the Minneapolis Convention Center.

Attendees are invited to visit Integer at booth #3011 to learn more about Integer’s range of innovative end-to-end medical device design, development and manufacturing solutions.

During MD&M Minneapolis, the Integer team will be on hand to discuss how we blend our technology, expertise and resources to amplify our customers’ innovation and increase speed to market, as well as specific capabilities and solutions to enable cardio & vascular, cardiac rhythm management, and neuromodulatio…

Why linking clinical trials to real-world data is the critical next step for medical device development

Connecting medical device clinical trials to real-world data (RWD) helps demonstrate efficacy, safety and cost-effectiveness.

Mehdi NajafZadeh, Medidata

Medical device and diagnostics manufacturers need to build data linkage into their clinical trial planning today to remove silos and mobilize efficient use of data sources for better clinical evidence generation in the years to come.[Illustration via Adobe Stock]

Medical device and diagnostics manufacturers face mounting pressure from regulators, payors and providers to provide more holistic evidence to demonstrate the efficacy, safety, and cost-effectiveness of their products.

To address these increasing requirements — as well as accelerate study timelines and reduce clinical trial burden — medical device sponsors are seeking innovative solutions. Connecting clinical trials to real-world data (RWD) is an effective approach to capture the information nee…

Nissha Medical Technologies wins FDA approval of its HeartSync defibrillation electrodes

NEWS RELEASE: Nissha Medical Technologies announces FDA PMA approval of its HeartSync defibrillation electrodes

Buffalo, New York, July 11, 2023: Nissha Medical Technologies (NMT) is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for its HeartSync defibrillation electrodes.

The HeartSync defibrillation electrodes offer several key advantages over traditional defibrillation electrodes currently available on the market including:

Enhanced patient comfort thanks to smaller pad size, which allows easy positioning around the heart and reduces pressure points from larger pads. Greater efficiency with lead-wire length options up to 60 in., which provide greater maneuverability and flexibility than standard lengths while maintaining safety standards. Energy distribution through the new conductor plate shape featuring a larger surface area per each terminal plate compared to other brands. Improved adhesiveness du…

Polymer supplier Raumedic names new CFO

NEWS RELEASE: Dr. Robert Schilling appointed as new CFO of RAUMEDIC AG

Raumedic CFO Robert Schilling [Photo courtesy of Raumedic]

HELMBRECHTS, October 5, 2023 – The Supervisory Board of RAUMEDIC AG, a leading global provider of polymer-based product solutions for the medical and pharmaceutical industries, has appointed Dr. Robert Schilling as Chief Financial Officer (CFO) and member of the Executive Board, effective October 1, 2023. Schilling succeeds Daniel Seibert, who is leaving the company at his own request after almost five years.

Mr. Schilling has extensive expertise in finance and controlling, which he has demonstrated in his career in various industries – most recently at Gerresheimer AG as Global Vice President Finance & Controlling in the Medical Systems Division.

Juergen Werner, Chairman of the Supervisory Board of RAUMEDIC AG, explains the decision in favor of Schilling: R…

Sticky business: Six wearable device adhesion tips from iRhythm CTO Mark Day

How to find the right balance between performance and patient comfort in wearable device adhesion.

iRhythm’s next-generation Zio cardiac monitoring patch can be worn for up to 14 days. [Photo courtesy of iRhythm]

iRhythm’s next-generation Zio cardiac monitoring patch is smaller, lighter and thinner — three qualities that also assist the wearable device’s adhesion.

Adhesion is a one of the leading challenges for wearable device developers. iRhythm Chief Technical Officer Mark Day discussed how his team designed the latest Zio patch to balance performance and patient comfort.

“So much of what we want to do is try and think about unmet needs and patient monitoring,” Day said in an interview with Medical Design & Outsourcing. “It’s really about raising the bar of performance by miniaturizing to ensure that we can get an already very compliant device even better.&…

This robotic tech could help detect breast cancer early

Researchers developed this robotIc radial palpatIon device for breast exams. [Photo by George Jenkinson/University of Bristol]

Researchers at the University of Bristol have developed new robotic technology that could improve the way women monitor their breast health.

This manipulator device, based at the Bristol Robotics Laboratory, applies specific forces similar to those used by human examiners, but its sensor technology can detect deeper lumps.

The system is designed to provide accessible and safe electronic clinical breast exams (CBEs) with accurate results, the researchers said.

These examinations require precision, repeatability and accuracy. A range of existing automatic and semi-automatic devices have been proposed to aid in optimizing the task, especially in difficult-to-detect and hard-to-reach situations, like minimally invasive surgery.

The Bristol research team — a mix of postg…